Top
image credit: Pixabay

Ortho and BARDA partner on high-specificity antibody tests

June 17, 2020

Category:

Ortho Clinical Diagnostics and the US Biomedical Advanced Research and Development Authority (BARDA) are working together to advance the development of Ortho’s IgG Covid-19 antibody tests.

BARDA has awarded Ortho $678,000 to support the company’s antibody testing programme.

Ortho manufactures two Covid-19 antibody tests: one total antibody test for IgA, IgM and IgG antibodies and one solely for IgG antibodies, which appear in a patient’s blood in the later phase of the infection and remain at elevated levels even after recovery. Both have been granted Emergency Use Authorisation (EUA) by the US Food and Drug Administration (FDA).

Read More on medicaldevice-network.com